TOP GUIDELINES OF TRASTUZUMAB HOW DOES IT WORK

Probably the most under-investigated “driving forces” involved with trastuzumab resistance is PTEN. Nagata et al. (2004) noted which the lack of PTEN was observed in 36% of HER2-positive Most important breast tumor specimens from sufferers with phase IV ailment. Furthermore, In addition they showed that sufferers with PTEN-deficient tumors expe